Sigyn Therapeutics, Inc. SIGY
0.03 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
0.0278 Day range 0.0303
0.01 52-week range 2.00
- YTD
- -98.36%
- 1 year
- -98.60%
- Market cap
- 151.18K
- EPS (ttm)
- -1.93
- YTD return
- -98.36%
- 1-year return
- -98.60%
- Volume
- 2.00K
- Avg volume
- 9.74K
- Open
- 0.0303
- Previous close
- 0.028
- Day's range
- 0.0278 – 0.0303
- 52-week range
- 0.01 – 2.00
2Y -4.7720 (-99.42%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 19, 2024 | Sep 1, 2024 | 0.00 | -0.94 | — | — |
| Aug 19, 2024 | Jun 1, 2024 | 0.00 | -0.70 | — | — |
| May 14, 2024 | Mar 1, 2024 | 0.00 | -0.62 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | -0.80 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | -0.80 | — | — |
| May 16, 2023 | Mar 1, 2023 | 0.00 | -1.20 | — | — |
News
Oragenics Signs LOI To License Certain Disease Indications Of CardioDialysis, Blood Purification Technology, From Sigyn Therapeutics 
Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation 
Head-To-Head Analysis: Sigyn Therapeutics (OTCMKTS:SIGY) vs. Shuttle Pharmaceuticals (NASDAQ:SHPH) 
Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX 
Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX 
Sigyn Therapeutics to Present at the Life Sciences Virtual Investor Forum on September 18th 
RETRANSMISSION: Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc. 
Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc. 
Sigyn Therapeutics to Present at Tomorrow's Small Cap Growth Virtual Investor Conference 
Sigyn Therapeutics™ to Present at Tomorrow's Emerging Growth Conference
Your note
Sign in to keep a note on SIGY — it syncs with the Stock Master app.